Plamen Kozlovski

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli et al. · JACC Heart Failure · 2017 · 162 citations · Full text

Medicine, Cardiology, Pharmacology +17

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Steven E. Nissen, Kathy Wolski, Leslie Cho et al. · Open Heart · 2022 · 127 citations · Full text

Public Health, Cardiology, Health Sciences +17

Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)

Leslie Cho, Stephen J. Nicholls, Børge G. Nordestgaard et al. · American Heart Journal · 2025 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Wolfgang Kothny, James E. Foley, Plamen Kozlovski et al. · Diabetes Obesity and Metabolism · 2012 · 99 citations

Medicine, Pharmacology, Pharmacotherapy +16

PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

H.‐J. Lüddeke, Séamus Sreenan, Stefan Aczél et al. · Diabetes Obesity and Metabolism · 2006 · 86 citations

Medicine, Endocrinology, Internal Medicine +17